Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.78
-0.25 (-1.09%)
At close: Jul 24, 2026, 4:00 PM EDT
22.73
-0.05 (-0.22%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $35 | Buy | Reiterates | $35 | +53.64% | Jul 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $29 | Buy | Reiterates | $29 | +27.30% | Jun 24, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $31 | Buy | Reiterates | $30 → $31 | +36.08% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $37 | Buy | Maintains | $37 | +62.42% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +62.42% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |